These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 13413145

  • 1. The inhibitory action of some antimalarial drugs and related compounds on the hexokinase of yeast and of Plasmodium berghei.
    FRASER DM, KERMACK WO.
    Br J Pharmacol Chemother; 1957 Mar; 12(1):16-23. PubMed ID: 13413145
    [Abstract] [Full Text] [Related]

  • 2. Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
    Skinner-Adams TS, Fisher GM, Riches AG, Hutt OE, Jarvis KE, Wilson T, von Itzstein M, Chopra P, Antonova-Koch Y, Meister S, Winzeler EA, Clarke M, Fidock DA, Burrows JN, Ryan JH, Andrews KT.
    Commun Biol; 2019 Mar; 2():166. PubMed ID: 31069275
    [Abstract] [Full Text] [Related]

  • 3. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B.
    J Ethnopharmacol; 2015 Aug 22; 172():214-8. PubMed ID: 26129936
    [Abstract] [Full Text] [Related]

  • 4. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR, da Silva JM, Carlos BC, da Fonseca CC, de Souza LS, Lopes FV, de Paula Dias RM, Moreira PO, Abramo C, Viana GH, de Pila Varotti F, da Silva AD, Scopel KK.
    Bioorg Med Chem Lett; 2015 Jun 01; 25(11):2308-13. PubMed ID: 25920564
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo.
    Tedlaouti F, Gasquet M, Delmas F, Timon-David P, Madadi NE, Vanelle P, Maldonado J.
    J Pharm Belg; 1990 Jun 01; 45(5):306-10. PubMed ID: 2086754
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the ex vivo antimalarial activity of organotin (IV) ethylphenyldithiocarbamate on erythrocytes infected with Plasmodium berghei NK 65.
    Awang N, Jumat H, Ishak SA, Kamaludin NF.
    Pak J Biol Sci; 2014 Jun 01; 17(6):836-42. PubMed ID: 26035957
    [Abstract] [Full Text] [Related]

  • 7. The mosquito transmission of malaria: the effects of atovaquone-proguanil (Malarone) and chloroquine.
    Enosse S, Butcher GA, Margos G, Mendoza J, Sinden RE, Høgh B.
    Trans R Soc Trop Med Hyg; 2000 Jun 01; 94(1):77-82. PubMed ID: 10748906
    [Abstract] [Full Text] [Related]

  • 8. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
    Aroonsri A, Akinola O, Posayapisit N, Songsungthong W, Uthaipibull C, Kamchonwongpaisan S, Gbotosho GO, Yuthavong Y, Shaw PJ.
    Int J Parasitol; 2016 Jul 01; 46(8):527-35. PubMed ID: 27150044
    [Abstract] [Full Text] [Related]

  • 9. In Vitro Effect on Plasmodium falciparum and In Vivo Effect on Plasmodium berghei of Annomaal, an Oily Fraction Obtained from the Seeds of Annona squamosa.
    Sawant SS, Gabhe SY, Singh KK.
    Molecules; 2023 Jul 17; 28(14):. PubMed ID: 37513343
    [Abstract] [Full Text] [Related]

  • 10. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R, Frame IJ, Sosa Y, Akabas MH.
    Int J Parasitol Drugs Drug Resist; 2016 Apr 17; 6(1):1-11. PubMed ID: 26862473
    [Abstract] [Full Text] [Related]

  • 11. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W, Fink E.
    Ann Trop Med Parasitol; 1979 Dec 17; 73(6):505-26. PubMed ID: 120142
    [Abstract] [Full Text] [Related]

  • 12. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U, Singh RS, Alcorn J, Hickman MR, Sciotti RJ, Leed SE, Lee PJ, Roncal N, Dimmock JR.
    Bioorg Med Chem; 2013 Dec 01; 21(23):7250-6. PubMed ID: 24139941
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antimalarial activity of a 4',5'-unsaturated 5'-fluoroadenosine mechanism-based inhibitor of S-adenosyl-L-homocysteine hydrolase.
    Bitonti AJ, Baumann RJ, Jarvi ET, McCarthy JR, McCann PP.
    Biochem Pharmacol; 1990 Aug 01; 40(3):601-6. PubMed ID: 2200410
    [Abstract] [Full Text] [Related]

  • 17. Substrate and Inhibitor Specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1.
    Arora A, Deniskin R, Sosa Y, Nishtala SN, Henrich PP, Kumar TR, Fidock DA, Akabas MH.
    Mol Pharmacol; 2016 Jun 01; 89(6):678-85. PubMed ID: 27048953
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Isolation and identification of carotenoid-producing yeast and evaluation of antimalarial activity of the extracted carotenoid(s) against P. falciparum.
    Sinha S, Chakrabarti A, Singh G, Kumar KK, Gaur NA, Arora A, Singh KN, Singh S, Paul D.
    Biol Futur; 2021 Sep 01; 72(3):325-337. PubMed ID: 34554551
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.